Genflow Biosciences plc (LON:GENF – Get Free Report) rose 21.9% during trading on Monday . The stock traded as high as GBX 2.04 and last traded at GBX 2.04. 17,691,867 shares traded hands during mid-day trading, an increase of 678% from the average session volume of 2,273,904 shares. The stock had previously closed at GBX 1.67.
Genflow Biosciences Trading Up 21.9%
The company has a market capitalization of £11.55 million, a P/E ratio of -6.14 and a beta of 2.30. The stock’s fifty day moving average is GBX 2.03 and its 200 day moving average is GBX 2.05.
Genflow Biosciences (LON:GENF – Get Free Report) last announced its quarterly earnings results on Thursday, April 30th. The company reported GBX (0.33) earnings per share (EPS) for the quarter. Genflow Biosciences had a positive return on equity of 332.06% and a negative net margin of 170.64%.
Genflow Biosciences Company Profile
Genflow Biosciences plc is a UK based biotech company with R&D facilities in Belgium and a US office in Cambridge, MA, driven by one mission: to deliver therapeutics that potentially halt or slow the ageing process in humans and dogs.
The company’s lead compound works through the delivery of a centenarian variant of the SIRT6 gene and has yielded promising preclinical results.
Featured Articles
- Five stocks we like better than Genflow Biosciences
- SpaceX’s First Earnings Report Could Decide Whether Shorts or Bulls Have Control
- Why Rare Earth Processing Could Be the Real 2027 Opportunity
- The S&P 493 Are Staging a Comeback—This Value ETF Offers Broad Exposure
- TSMC Insiders Are Buying the Pullback—But Is the Signal as Bullish as It Looks?
Receive News & Ratings for Genflow Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genflow Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.
